Bioxyne Limited announced the appointment of Dr. Peter French as an executive director of the company. Dr. French is a cell and molecular biologist who has been involved in the corporate biotechnology industry since 1998, when he founded stem cell storage company Cryosite Limited. From 2002 to 2006 he served as Managing Director of Probiomics Limited (a predecessor of Bioxyne) where he led the launch of six probiotic products based on the Company's Lactobacillus fermentum PCC strain in pharmacies in Australia and Singapore, as well as setting up a number of clinical studies on PCC.

Until December 2015, Dr. French was the Managing Director of Benitec Biopharma Limited (ASX.BLT), Australia's only gene therapy company, which also successfully dual listed on the NASDAQ in late 2015.